Wang X, Wang Z, Chen H, Luo Y, Li S, Luo X
Heliyon. 2024; 10(17):e37230.
PMID: 39286117
PMC: 11402753.
DOI: 10.1016/j.heliyon.2024.e37230.
Khan F, Pandey P, Verma M, Upadhyay T
Biomolecules. 2024; 14(2).
PMID: 38397437
PMC: 10886526.
DOI: 10.3390/biom14020200.
Jiang G, Zhou X, Hu Y, Tan X, Wang D, Yang L
Cancer Biol Ther. 2024; 25(1):2302413.
PMID: 38356266
PMC: 10878017.
DOI: 10.1080/15384047.2024.2302413.
Gong X, Liu Y, Liang K, Chen Z, Ding K, Qiu L
Int J Mol Sci. 2023; 24(21).
PMID: 37958903
PMC: 10650020.
DOI: 10.3390/ijms242115920.
Zieniuk B, Pawelkowicz M
Metabolites. 2023; 13(10).
PMID: 37887406
PMC: 10608718.
DOI: 10.3390/metabo13101081.
Cucurbitacin E Exerts Anti-Proliferative Activity via Promoting p62-Dependent Apoptosis in Human Non-Small-Cell Lung Cancer A549 Cells.
Hsu H, Lin B, Lin Y, Tu C, Nguyen N, Wang C
Curr Issues Mol Biol. 2023; 45(10):8138-8151.
PMID: 37886957
PMC: 10605876.
DOI: 10.3390/cimb45100514.
Natural STAT3 Inhibitors for Cancer Treatment: A Comprehensive Literature Review.
Zarezadeh S, Sharafi A, Erabi G, Tabashiri A, Teymouri N, Mehrabi H
Recent Pat Anticancer Drug Discov. 2023; 19(4):403-502.
PMID: 37534488
DOI: 10.2174/1574892818666230803100554.
Apoptotic and antimetastatic effect of cucurbitacins in cancer: recent trends and advancement.
Kumar A, Sharma B, Sharma U, Parashar G, Parashar N, Rani I
Naunyn Schmiedebergs Arch Pharmacol. 2023; 396(9):1867-1878.
PMID: 37010571
DOI: 10.1007/s00210-023-02471-z.
Cucurbitacins as Potent Chemo-Preventive Agents: Mechanistic Insight and Recent Trends.
Tuli H, Rath P, Chauhan A, Ranjan A, Ramniwas S, Sak K
Biomolecules. 2023; 13(1).
PMID: 36671442
PMC: 9855938.
DOI: 10.3390/biom13010057.
Modulation of Cytoskeleton, Protein Trafficking, and Signaling Pathways by Metabolites from , and Plant Families.
Patel A, Rasheed A, Reilly I, Pareek Z, Hansen M, Haque Z
Pharmaceuticals (Basel). 2022; 15(11).
PMID: 36355554
PMC: 9698530.
DOI: 10.3390/ph15111380.
Pharmacokinetics and Biological Activity of Cucurbitacins.
Delgado-Tiburcio E, Cadena-Iniguez J, Santiago-Osorio E, Ruiz-Posadas L, Castillo-Juarez I, Aguiniga-Sanchez I
Pharmaceuticals (Basel). 2022; 15(11).
PMID: 36355498
PMC: 9696414.
DOI: 10.3390/ph15111325.
[Research Progress on Pathogenic Mechanism and Potential Therapeutic Drugs of
Idiopathic Pulmonary Fibrosis Complicated with Non-small Cell Lung Cancer].
Xiao T, Bao J, Liu X, Huang H, Zhou H
Zhongguo Fei Ai Za Zhi. 2022; 25(10):756-763.
PMID: 36167462
PMC: 9619346.
DOI: 10.3779/j.issn.1009-3419.2022.101.45.
Autophagy in health and disease: From molecular mechanisms to therapeutic target.
Lu G, Wang Y, Shi Y, Zhang Z, Huang C, He W
MedComm (2020). 2022; 3(3):e150.
PMID: 35845350
PMC: 9271889.
DOI: 10.1002/mco2.150.
Novel Triterpenoid Alkaloids With Their Potential Cytotoxic Activity From the Roots of .
Wang H, Ma G, Wang H, Li L, Dong A, Liu H
Front Chem. 2022; 10:885487.
PMID: 35572103
PMC: 9099095.
DOI: 10.3389/fchem.2022.885487.
Targeting ERK induced cell death and p53/ROS-dependent protective autophagy in colorectal cancer.
Mi W, Wang C, Luo G, Li J, Zhang Y, Jiang M
Cell Death Discov. 2021; 7(1):375.
PMID: 34864826
PMC: 8643355.
DOI: 10.1038/s41420-021-00677-9.
Qiyusanlong Formula Induces Autophagy in Non-Small-Cell Lung Cancer Cells and Xenografts through the mTOR Signaling Pathway.
Gao Y, Wang X, Yang Q, Wang X, Zhang X, Tong J
Evid Based Complement Alternat Med. 2021; 2021:5575453.
PMID: 34093717
PMC: 8164545.
DOI: 10.1155/2021/5575453.
Use of cucurbitacins for lung cancer research and therapy.
Liu M, Yan Q, Peng B, Cai Y, Zeng S, Xu Z
Cancer Chemother Pharmacol. 2021; 88(1):1-14.
PMID: 33825035
DOI: 10.1007/s00280-021-04265-7.
Targeting mTOR by CZ415 Suppresses Cell Proliferation and Promotes Apoptosis via Lipin-1 in Cervical Cancer In Vitro and In Vivo.
Zhang J
Reprod Sci. 2020; 28(2):524-531.
PMID: 32944878
DOI: 10.1007/s43032-020-00313-4.
AMPK/mTOR/ULK1 Axis-Mediated Pathway Participates in Apoptosis and Autophagy Induction by Oridonin in Colon Cancer DLD-1 Cells.
Bu H, Liu D, Zhang G, Chen L, Song Z
Onco Targets Ther. 2020; 13:8533-8545.
PMID: 32904616
PMC: 7457577.
DOI: 10.2147/OTT.S262022.
Phytochemical Targeting of STAT3 Orchestrated Lipid Metabolism in Therapy-Resistant Cancers.
Tse C, Warner A, Farook R, Cronin J
Biomolecules. 2020; 10(8).
PMID: 32731620
PMC: 7464013.
DOI: 10.3390/biom10081118.